»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 0>Y3xNb
g 4+K"Q/M
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 It3k#A0
k|OM?\
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© #Us<#"fC
1.Antigen presenting cell£¨APC£© -;cF)C--12
2.Activation induced cell death£¨AICD£© lJ3VMYVrUP
3.Chemokine i$kB6B#==
4.Major histocompatibility complex£¨MHC£© / =9Y(v
5.immunotolerance |&K;*g|a
t,YRM$P
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© |47t+[b
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ N[eLQe]q
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà FWu:5fBZY
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ =|J*9z;
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ :?~)P!/xl5
5.±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌصã PxYK)n9&
ObM/~{rKx
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© )ThNy:4
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ (+gTIcc
>
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ 7=G6ao7
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ <yl@!-'J7
0WzoI2Q
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ G9XkimQ'
Q>Ct]JW&
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 @~vg=(ic(
yl?LXc[)
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ P,ZQ*Ju
1.Antigenic determinant hqeknTGsIn
2.IgSF z~f;}`0
3.MBL;¾¶ 64b AWHv
4.chemokine <Z t ]V`-
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ YKUAI+ks
6.TCR-CD3¸´ºÏÎï V}TPt6C2
7.FADD£¨Fas-associated protein with death domain£© Z:^<NdKe
8.AIDS 8;`
B3N7
9.Tumor rejection antigen *CGHp8
10.AICD q=e;P;u
!^Ay!
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ 2F
dwX,O.
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© X*#\JF4$i
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ -hfDf{QN
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ 7V^j9TC
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì IM6n\EZ^
o1 27? ^
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ .+Q1h61$T
bi-Am/9
I;AS.y
רҵ¿Î ÃâÒßѧ B^M
L}$
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê 44n
41.Q]
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell W;yg{y
5. Fc¦Å receptor 6. Cytokine *kf%?T.
¶þ¡¢ ÎÊ´ðÌâ ej7N5~!,s
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØɱÉË°Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 ^4JK4+!Zfq
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ 41B.ZE+*qd
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁÜ°ÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ ZJ)>gV
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâЩÌصãµÄÉúÎïѧÒâÒ壿 N1E9w:T`
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦ÓᣠUC`sq-n
|]:6IuslJ
`{yD\qDyX
<Qbqxw
u ?F},VL;
;eF
V}DWW
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ]LCL?zAzH!
]We0 RD"+
<vs*aFq
רҵ¿Î ÃâÒßѧ ^eV K.
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê p&xj7qwp@F
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen LEg|R+6E
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin b
V_<5PHP
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test >_\]c-~<
9. Hybridoma technic 10.Mitogen Q^Vch(`&P
11.Dentritic cell 12.Immunoproliferation RT%{M1tkS
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ ~T._v;IT
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨Äļ¸¸öÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ 5M>SrZH
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦Óᣠ4dz Ym+vJm
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ 1?TgI0HS
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ \WUCm.w6\%
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ C-Y7n5
A6;[r #C
&`"uKO]
#)T'a
s,laJf
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ {v3@g[:|
#b&=CsW`
hg^klQD
רҵ¿Î ÃâÒßѧ ~a>3,v-
Ò»¡¢ Ãû´Ê½âÊÍ q~\[P4m
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï o:%;AOcl
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà r_V^sX
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ T< <N U"n
¶þ¡¢ ÎÊ´ðÌâ 'Te'wh=Y
1¡¢ TÁÜ°Íϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ bOlb
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁÜ°Íϸ°ûºÍЧӦÎïÖÊ¡£ tgrZs8?
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆ乲ͬÌص㼰ÓëÁÙ´²µÄ¹Øϵ¡£ FxX nX
4¡¢ ºÎνÁÜ°Íϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ m`,h nDp
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØϵͳ£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ Nm0|U.<
erV&N,cI
T,4REbm^
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ WZ@$bf}f0
[4}U*\/>C
)|U+<r<
רҵ¿Î ÃâÒßѧ V#-8[G6Ra
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê 'p,54<e
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR k'd=|U;(FV
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA W%
}zwQ
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM k?Iq 6
¶þ¡¢ ÎÊ´ðÌâ
K&iU
+
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌص㡣 n\4sNoFI
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ Y{dj~}mM+
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖƵÄÒìͬµã¡£ `c_Wk]i
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆ书ÄÜ¡£ <~.1>CI9D3
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ 1&YkRCn0
ohB@ij C!
RMxFo\TK;
jL#`CD
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ,y*|f0&"~
n]WVT@
<825?W|
רҵ¿Î ÃâÒßѧ 69{q*qCW
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê lyyRyFfQ
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule fnU;DS]W
5. Autogous mixed lymphoyte reaction [Xo[J?w],2
¶þ¡¢ ÎÊ´ðÌâ
i(n BXV{
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ ABnJ{$=n#
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ : ]~G9]R`
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠr/mKuGa]
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹Øϵ£¿ /gq
VXDY+`
>Y"Ru#Ju9
pK@8= +
jB%aHUF;
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ UrEfFtH'
PFPZ]XI%F
EHX/XM
רҵ¿Î ÃâÒßѧ xg_9#
J'Y;j^
3/0E9'
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê *'h J5{U
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance MI\35~JAN
5. Delayed type hypersensitivity fy|$A@f
¶þ¡¢ ÎÊ´ðÌâ \d}>@@U&
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ <#F@OU
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ "TP^:Ln
3. ¼òÊöHLAÓëҽѧµÄ¹Øϵ¡£ nb}rfd.
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ4Bz:n
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷Óᣠnb_$g@ 03
V(3=j)#
V3<H8pL
?n(OH~@$i
I> BGp4 AQ
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ jWqjGX`
= 4 wf
G_/DzJBF
רҵ¿Î ÃâÒßѧ l~Rd\.O
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê kmT5g gy
1. hypersensitivity 2. cluster of differentiation 6&`hf >
3. adhesion molecules 4. supper antigen 5. split tolerance ce:p*
¶þ¡¢ ÎÊ´ðÌâ !\5w<*p8
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ 2xK v;
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ R,dbq4xkl
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ +^|_vq^XR
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ 6W[~@~D=
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ {ep(_1
qV79bK
:T )R
;E@
j9xu21'!%
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ n#^ii/H
רҵ¿Î ÃâÒßѧ g5:?O,?
Ò»¡¢ Ãû´Ê½âÊÍ E
.N
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å TyhO+;
5. GVHR Z0%:j\W4c
¶þ¡¢ ÎÊ´ðÌâ Kk`LuS?
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷ÓᣠQ$(Fma 4a
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌصãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ KX
J7\
}
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌص㡣 {B-
*w%}HU
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ U0U y
C
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ 2Gh&h(
_ee<i8_Va
|'-%d^Z
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ _&%FGcAS
?4^ 0xGyE
:V1j*)
רҵ¿Î ÃâÒßѧ #%EHcgF
Ò»¡¢Ãû´Ê½âÊÍ u'nQC*iJb
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å (9R;-3vY:S
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ te4=
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ @VPmr}p:{
11. »ìºÏÁÜ°Íϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ .5uqc.i"f
Èý¡¢ ÎÊ´ðÌâ 5owK2
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ st
UUez>
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ |kP utB
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà zy5F
O<->
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ xv&h>GOg
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ C~R
?iZ.&U
]f0OmUHR5i
sQe
GT)/|
K_@?Q@#YhR
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ kg
8Dn
\5 rJ
SnR2o3r-Of
רҵ¿Î ÃâÒßѧ !|up"T I
Ò»¡¢Ãû´Ê½âÊÍ SiUu**zC
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó +FAj30
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁÜ°Íϸ°ûµÄ±íÃæ±êÖ¾ 9!
/kyyU
Èý¡¢ ÎÊ´ðÌâ /0 4US5En
1. ¼òÊöTÁÜ°Íϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ FF~r&h8H
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ U8AH,?]#
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ ddyX+.LMk
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ (
*Xn"o
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ marZA'u%B1
g(WP
yji[Yde;|
10i$ b<O
msM1K1er
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ
".tL+A[
Ò»¡¢Ãû´Ê½âÊÍ zD79 M
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï o]Rlivahm
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó KGHSEZi]
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ m$kQbPlatN
¶þ¡¢ ÎÊ´ðÌâ 9MYk5q.X:
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ *Bq}.Yn
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ 8&)v%TX
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ $KO2+^%y
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ DzQBWY]
)
ksOGCd^G7
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ u]};QR
Ò»¡¢ Ãû´Ê½âÊÍ lGl'A}]#$
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ kkF)Tro\
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ e~9O#rQI
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© x8PT+KC
10¡¢ ÒõÐÔÑ¡Ôñ x
i=ApwNj
¶þ¡¢ ÎÊ´ðÌâ iqQT ^
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 .p&@;fZ
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ K>@yk9)vi
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 ]
3"t]U'f
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ tcuwGs>_
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. bf"'xn9
LH8jT
wZiUzS;v
N1c=cZDV
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ f"
QiVJq
:8A+2ra&
Z<-_Y]4j
רҵ¿Î ÃâÒßѧ Az`Aa0h]7
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ 4wl1hp>,
1. Cytokines 2. adhesion molecules 3. graft versus host reaction ;]>kp^C#
4. immunologic tolerance 5. Opsonization 5i!Q55Yv=,
Èý¡¢ ÎÊ´ðÌâ 9-KhJq%
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷Óᣠ}TmOoi(X@
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ ,,'jyqD
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ &S,D;uhF
4. ÃâÒßϵͳɱÉË°Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ 2$JGhgDI
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ *@2Bh4
MtLWpi u@[
`8:)? 0Ez
yn4T
!r "
"O&93#8
PsY![CPrW
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ pP. _%5
[GLH8R
`fu_){
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ ZZw`8 E
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ M";qo6
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê fE#(M +(<
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ o.+;]i}D
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û ^9g$/8[^c_
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö 9BCW2@Kp
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð 6K/RO)
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖƱ¸ÔÀí¡£ 7aG
.?Ca%
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ .Ro/ioq
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃ濹ԺͱíÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© =
tv70d'
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ /F*Y~>*% 1
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ ?bTfQH
vX
vwCQvt
`+7F H
4ot<Uw5
!ifU}qFzK
:ym?]EL4o
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ o2/:e
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ =~D? K9o
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ Ss3p6%V/
({f}Z-%
Ò»¡¢ Ãû´Ê½âÊÍ =%Y1] F
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß OgQdyU
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò L*@`i ]jl
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô sS D8Sx/
¶þ¡¢ÎÊ´ðÌâ |;ztK[(
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ --yF%tRMP
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì HiCh:IP7>/
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì ]e>qvSuYh
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ v 6 ~9)\!j
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ N5Js.j>z
O<u=Vz3c~0